Wolverine Asset Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Wolverine Asset Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,036	Closed	-$3.62M	–	2327
2022 Q3	$3.62M	Sell	1,036 -9	-0.9%	-$31.4K	0.04%	399
2022 Q2	$3.63M	Buy	1,045 +112	+12%	+$389K	0.04%	392
2022 Q1	$3.25M	Buy	+933	New	+$3.23M	0.03%	398

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Wolverine Asset Management's ZVSA Position: Q4 2022 in Review

Wolverine Asset Management sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,036 shares — an estimated $3.62M sold.

Wolverine Asset Management first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $3.63M in Q2 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Wolverine Asset Management reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 1,036 ZyVersa Therapeutics shares in Q4 2022, an estimated $3.62M.
Wolverine Asset Management first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
Wolverine Asset Management's ZyVersa Therapeutics position peaked at $3.63M in Q2 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.